CI

At a glance

ClinicalIndex Comparison Record
N/ATerminated· 4 enrolled
Drug / intervention
Device implantationprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04994886
NCT04994886N/ATerminated
Terminated

Restoring Hemodynamic Stability Using Targeted Epidural Spinal Stimulation Following Spinal Cord Injury

Jocelyne Bloch·interventional·Posted Aug 6, 2021·Updated Apr 29, 2025

In Brief

A clinical study evaluating Device implantation for Spinal Cord Injuries. Terminated early, enrolled 4 participants across 1 site.

Signals

Trial was terminated early

Detailed Summary

The purpose of this study is to stimulate the circuits in the spinal cord that are directly responsible for hemodynamic control to restore hemodynamic stability in patients with chronic cervical or high-thoracic spinal cord injury. The ultimate objective of this feasibility study is to provide preliminary safety and efficacy measures on the ability of the hemodynamic Targeted Epidural Spinal Stimulation (TESS) to ensure the long-term management of hemodynamic instability and reduce the incidence and severity of orthostatic hypotension and autonomic dysreflexia episodes in humans with chronic cervical or high-thoracic spinal cord injury. In addition, the long-term safety and efficacy of TESS on cardiovascular health, respiratory function, spasticity, trunk stability and quality of life in patients with chronic spinal cord injury will be evaluated.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesSwitzerland
Collaborators--

Timeline

N/ATerminatedFinished
20222023202420252026
First PostedAug 6, 2021
Enrollment StartJun 8, 2021
Primary CompletionDec 18, 2024
TodayJul 1, 2026
Enrollment to primary: 3.5 yearsPosted 4.9 years ago

Interventions

Device implantationprocedure

The intervention involves the insertion of 2 lead electrodes (Specify Surescan 5-6-5 Leads, Model 977C190 Medtronic) epidurally over the dorsal aspect of the spinal cord through 2 laminectomies and two implantable pulse generators (Intellis™ with AdaptiveStim™, Model 97715 Medtronic) in the abdomen of the participant.